"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Iowa Heart Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 28 clinical trials were completed, i.e. on average, 71.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iowa Heart Center" #1 sponsor was "Abbott Medical Devices" with 15 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 13 trials sponsored, "Medtronic" with 5 trials sponsored, "Amgen" with 2 trials sponsored and "AtriCure, Inc." with 2 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Heart Center" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Iowa Heart Center" are "Heart Failure" (15 trials), "Coronary Artery Disease" (10 trials), "Atrial Fibrillation" (7 trials), "Bradycardia" (5 trials) and "Hypertension" (3 trials). Many other conditions were trialed in "Iowa Heart Center" in a lesser frequency.

Most popular intervention types in "Iowa Heart Center" are "Device" (47 trials), "Drug" (13 trials), "Other" (5 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "LARIAT + PVI" (2 trials), "Micra Pacemaker Implant" (2 trials), "Oral treprostinil" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Iowa Heart Center" are 68 trials for "All" genders.

Currently, there are NaN active trials in "Iowa Heart Center". undefined are not yet recruiting, 10 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Iowa Heart Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Iowa Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 35 trials that are defined as “Not Applicable".